Nuwellis (NUWE)
(Delayed Data from NSDQ)
$1.81 USD
+0.05 (2.84%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $1.88 +0.07 (3.87%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Nuwellis, Inc. [NUWE]
Reports for Purchase
Showing records 1 - 7 ( 7 total )
Company: Nuwellis, Inc.
Industry: Medical - Instruments
Quelimmune Distribution Deal With ICU Terminated, But Was Not In Our Model
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Nuwellis, Inc.
Industry: Medical - Instruments
Aquadex Leads To Statistically Significant ADHF Readmission Rate Decreases
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Nuwellis, Inc.
Industry: Medical - Instruments
Company: Nuwellis, Inc.
Industry: Medical - Instruments
2Q24: REVERSE-HF Trial >33% Enrolled, GPM Increasing, Softer Pediatric Rev
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Nuwellis, Inc.
Industry: Medical - Instruments
Company: Nuwellis, Inc.
Industry: Medical - Instruments
We are initiating coverage with a Buy rating and a 12-month price target of $17
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Nuwellis, Inc.
Industry: Medical - Instruments
|